Uozumi Takeshi

Cloning and structural analysis of the calf prochymosin gene

Abstract Calf prochymosin (cPC) gene was cloned from calf abomasum DNA by using a cloned cPC cDNA as a probe. The cPC gene spans approx. 10.5 kb and consists of 9 exons and 8 introns. The positions of exon-intron junctions coincide completely with those in the human pepsinogen gene. Analysis of 5′ -flanking region sequence and S1 nuclease mapping revealed that the transcriptional start point was located 25 bp upstream from the start codon and that the putative transcriptional promoter sequences (TATA box and CCAAT box) were located in − 30 and − 90 regions, respectively. Some distinctive sequences possibly functioning as regulatory signals for gene expression are present at the 5′-flanking region.

Expression of cloned calf prochymosin gene sequence in Escherichia coli

Abstract An expression plasmid for calf prochymosin (prorennin) cDNA was constructed. The plasmid (pCR301) contains the lac UV5 promoter in front of the fused gene in which the codons for the N-terminal four amino acids of prochymosin cDNA were replaced with those for the N-terminal ten amino acids of β-galactosidase. Synthesis of the fused protein with the expected M r was detected immunologically in Escherichia coli harboring pCR301. The product seemed to be localized in the cell membrane of the bacterial host.

Identification of a unique specificity determinant of the colicin E3 immunity protein.

Plasmid immunity to a nuclease-type colicin is defined by the specific binding of an immunity (or inhibitor) protein, Imm, to the C-terminal nuclease domain, T2A, of the colicin molecule. Whereas most regions of colicin operons exhibit extensive sequence identity, the small plasmid region encoding T2A and Imm is exceptionally varied. Since immunity is essential for the survival of the potentially lethal colicin plasmid (Col), we inferred that T2A and Imm must have co-evolved, retaining their mutual binding specificities. To evaluate this co-evolution model for the col and imm genes of ColE3 and ColE6, we attempted to obtain a stabilized clone from a plasmid which had been destabilized with a non-cognate immunity gene. A hybrid Col, in which the immE3 gene of the ColE3 was replaced with immE6 from ColE6, was lethal to the host cells upon SOS induction. From among this suicidal cell population, we isolated a stabilized, i.e., evolved, clone which produced colicin E3 (E3) stably and exhibited immunity to E3. This change arose from only a single mutation in ImmE6, from Trp48 to Cys, the same residue as in the ImmE3 sequence. In addition, we constructed a series of chimeric genes through homologous recombination between immE3 and immE6. Characterization of these chimeric immunity genes confirmed the above finding that colicins E3 and E6 are mostly distinguished by only Cys48 of the ImmE3 protein.

Cloning of a streptomycin-production gene directing synthesis of N-methyl-L-glucosamine

Abstract A Streptomyces bikiniensis DNA fragment complementing a deficiency in streptomycin (Sm) production was cloned on the plasmid vector pIJ385. Host strain S. bikiniensis SD1 used as the recipient in cloning displayed deficiency in biosynthesis of N -methyl- l -glucosamine, one of the moieties of Sm. The cloned fragment on the multicopy plasmid pIJ385 conferred sevenfold increase in Sm production in comparison with the wild-type parental strain. By subcloning, the region complementing the Sm deficiency of SD1 was narrowed to a 3.0-kb fragment.